<DOC>
	<DOCNO>NCT03034811</DOCNO>
	<brief_summary>The primary objective study obtain implant survivorship clinical outcome data commercially available Persona Partial Knee System .</brief_summary>
	<brief_title>Persona Partial Knee Clinical Outcomes Study</brief_title>
	<detailed_description>The study design prospective , multicenter , noncontrolled study commercially available Persona Partial Knee . The study require site obtain IRB approval prior study enrollment . All potential study subject require participate Informed Consent Process . All study subject undergo preoperative clinical evaluation prior partial knee arthroplasty . Investigators collect clinical data require 2 year option continue follow-up assessment 10 year . Follow-up clinical visit include 3 month , 1 year , 2 , 5 , 10 year post-operatively . The primary objective study obtain implant survivorship clinical outcome data commercially available Persona Partial Knee System . The assessment include : implant survivorship base revision removal study device ; safety base incidence frequency adverse event ; clinical performance measure overall pain function , quality life data , radiographic parameter , survivorship .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Osteonecrosis</mesh_term>
	<criteria>Patient least 18 year age Patient qualify knee arthroplasty base upon physical exam medical history , meet approved indication use Persona Partial Knee system . Patient participate studyrelated Informed Consent process Patient willing able provide write Informed Consent sign date IRB/EC approve Informed Consent form Patient willing able complete schedule study procedure followup evaluation Independent study participation , patient candidate commercially available Persona Partial Knee , implant accordance product label Patient currently participate surgical intervention study pain management study Infection , sepsis , osteomyelitis Rheumatoid arthritis form inflammatory joint disease Insufficiency collateral , anterior posterior cruciate ligament would preclude stability device Full thickness damage weight bear area contralateral compartment Uncooperative patient patient neurologic disorder incapable follow direction Insufficient bone stock provide adequate support and/or fixation prosthesis Metabolic disorder may impair bone formation Osteomalacia Distant focus infection may spread implant site Rapid joint destruction , mark bone loss bone resorption apparent roentgenogram Vascular insufficiency , muscular atrophy , neuromuscular disease Incomplete deficient soft tissue surround knee Charcot 's disease Fixed varus deformity ( passively correctable ) great 15 degree Fixed flexion deformity ( passively correctable ) great 15 degree Patient pregnant consider member protect population ( e.g. , prisoner , mentally incompetent , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Noninflammatory degenerative joint disease</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Avascular necrosis</keyword>
	<keyword>Traumatic arthritis</keyword>
	<keyword>Partial knee arthroplasty</keyword>
	<keyword>Unicompartmental knee arthroplasty</keyword>
</DOC>